Dennis Thompson

HealthDay is a world-renowned news provider that has been producing award-winning content since 1998. The editorial team comprises award-winning health and medical journalism specialists with advanced degrees in the field and years of industry experience. HealthDay's content is used by leading media such as WebMD, American Heart Association, Merck Manual, US News and World Report, Medical publishers such as Elsevier, Haymarket Media, and Wolters Kluwer. The company takes utmost pride in being one of the most respected in the area for creating engaging content that delivers better outcomes for clients. HealthDay's mission is to create engaging content which delivers better outcomes for all of their clients.

Biography:  https://www.healthday.com/about-us

92%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

  • HealthDay has a strict editorial policy of being independent of any financial interests and relies on industry-respected sources and the latest scientific research for their content.

Conflicts of Interest

95%

Examples:

  • HealthDay provides content to leading media such as WebMD, American Heart Association, Merck Manual, US News and World Report, Medical publishers such as Elsevier, Haymarket Media, and Wolters Kluwer trust in HealthDay content.

Contradictions

95%

Examples:

  • Approximately 1 million new GLP-1 users were identified between 2011 and 2023.
  • The demand for GLP-1RAs has led to a nationwide drug shortage and issues with accessibility.

Deceptions

81%

Examples:

  • The articles fail to mention any potential side effects of GLP-1 drugs, such as nausea, vomiting, diarrhea, and kidney problems.

Recent Articles

GLP-1 Receptor Agonists Shift from Diabetes to Obesity Treatment: Implications and Trends

GLP-1 Receptor Agonists Shift from Diabetes to Obesity Treatment: Implications and Trends

Broke On: Tuesday, 23 July 2024 Since around 2020, GLP-1 receptor agonists (GLP-1 RAs) have seen a notable shift from treating type 2 diabetes to obesity in the US. This trend is driven by FDA approvals and the high prevalence of obesity, accounting for over 88% of new prescriptions being semaglutide. However, this shift raises concerns about potential drug shortages and disparities in access.
Three out of Five Parents Cook Specialized Meals for Picky Eaters: Experts Warn of Potential Unhealthy Habits

Three out of Five Parents Cook Specialized Meals for Picky Eaters: Experts Warn of Potential Unhealthy Habits

Broke On: Tuesday, 23 April 2024 A University of Michigan poll found that three out of five parents cook specialized meals for their picky-eating children, potentially fostering unhealthy eating habits. Parents should provide balanced meals with options and avoid pressuring food consumption to ensure a healthy diet.